Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s

NCT03457597 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Midazolam hydrochloride
DRUG: Metoprolol tartrate
DRUG: Pioglitazone hydrochloride
DRUG: Tolbutamide
DRUG: Omeprazole
DRUG: Relacorilant

Sponsor

Corcept Therapeutics